Baricent 4 (Baricitinib 4mg)

Baricent 4 (Baricitinib 4 mg) is a Janus kinase (JAK) inhibitor used for treating adult patients with moderately to severely active rheumatoid arthritis who have not responded adequately to TNF antagonist therapies.

As a generic version of Olumiant, Baricent 4 offers similar clinical effectiveness at a significantly lower cost, making it an affordable long-term treatment option.

Indications

Moderate to severe rheumatoid arthritis in adults
Patients with inadequate response to TNF inhibitors

Dosage & Administration

Recommended dose: 4 mg once daily
Can be taken alone or with methotrexate or other DMARDs

Limitations of Use

Do not use with other JAK inhibitors
Avoid combination with biologic DMARDs
Avoid strong immunosuppressants (e.g., azathioprine, cyclosporine)

Warnings & Precautions

Anemia: Avoid if hemoglobin < 8 g/dL
Lymphopenia: Avoid if ALC < 500 cells/mm³
Neutropenia: Avoid if ANC < 1000 cells/mm³

Side Effects

Upper respiratory tract infections
Herpes infections (cold sores, shingles)
Nausea

Cost & Savings

Baricent 4 is available at up to 80–90% lower cost compared to branded Olumiant in the USA and other countries.

Why Buy from India

WHO-GMP certified manufacturing
High-quality generic formulation
Significant price advantage
Reliable worldwide shipping

Prescribing Information

Refer to official FDA prescribing information or consult a licensed healthcare provider before use.